Vivantes - Netzwerk für Gesundheit GmbH

Hospital


Location: Berlin, Germany (DE) DE

ISNI: 000000404768412


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Präferenzen von Ärzten für die adjuvante Therapie des malignen Melanoms im Stadium IIB/C: Konzept für eine Industrie-unabhängige Befragungsstudie (2024) Kraaz A, Peitsch WK, Diehl K, Akbarzadeh D, Kromer C, Weilandt J Conference contribution, Abstract of a poster Adjuvante Therapieentscheidungen bei Patienten mit malignem Melanom im Stadium IIB/C und Stadium III im klinischen Alltag (2024) Mechow N, Peitsch WK, Diehl K, Ohletz J, Herz J, Eisert L, Harth W, Weilandt J Conference contribution, Abstract of lecture The Acute Care of Stroke Patients in German Stroke Units-an Analysis of DRG Data From 2021 and 2022. (2024) Neumann-Haefelin T, Bartig D, Faiss J, Schwab S, Nabavi D Journal article, Letter [Not Available]. (2024) Berg T, Aehling NF, Bruns T, Welker MW, Weismüller T, Trebicka J, Tacke F, et al. Journal article Endoscopic Resection Techniques for Precancerous and Early Cancerous Lesions in the Rectum Endoskopische Resektionsverfahren von flächigen Präkanzerosen und Frühkarzinomen im Rektum (2023) Hochberger J, Loss M, Kruse E Journal article, Review article Sleep quality, anxiety, symptoms of depression, and caregiver burden among those caring for patients with Dravet syndrome: a prospective multicenter study in Germany (2023) Maltseva M, Schubert-Bast S, Zöllner JP, Bast T, Mayer T, von Spiczak S, Ruf S, et al. Journal article S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“ – update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention (2023) Leiter U, Heppt M, Steeb T, Alter M, Amaral T, Bauer A, Bechara FG, et al. Journal article S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma"- update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care (2023) Heppt M, Leiter U, Steeb T, Alter M, Amaral T, Bauer A, Bechara FG, et al. Journal article S3-Leitlinie “Aktinische Keratose und Plattenepithelkarzinom der Haut“ – Update 2023, Teil 1: Therapie der aktinischen Keratose, Morbus Bowen, Cheilitis actinica, berufsbedingte Erkrankung und Versorgungsstrukturen (2023) Heppt M, Leiter U, Steeb T, Alter M, Amaral T, Bauer A, Bechara FG, et al. Journal article COMBI-r: A Prospective, Non-Interventional Study of Dabrafenib Plus Trametinib in Unselected Patients with Unresectable or Metastatic BRAF V600-Mutant Melanoma (2023) Berking C, Livingstone E, Debus D, Loquai C, Weichenthal M, Leiter U, Kiecker F, et al. Journal article